Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Recipient : X-Chem
Deal Size : Undisclosed
Deal Type : Collaboration
X-Chem Expands Collaboration with Orion for Early Drug Discovery
Details : The collaboration reinforces X-Chem’s position as a partner with capabilities that extend well beyond screening, offering discovery solutions designed to accelerate success in small molecule drug.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
April 30, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Recipient : X-Chem
Deal Size : Undisclosed
Deal Type : Collaboration